Home / PDA Letters (Cards)

PDA Letters (Cards)

U.S. FDA Rep Offers Overview on Visible Particulates

Rebecca Stauffer, PDA

Cell and Gene Manufacturing Grows in Singapore

Bruce Loxley, GSK, and Emily Cheah, Charles River Laboratories, Members-at-Large, PDA Singapore Chapter

Highly Potent APIs: Balancing Patient and Operator Safety

Rebecca Stauffer, PDA

PDA Comments: Drug Storage Regulations in Plain Language

Rebecca Stauffer, PDA

Robotics and AI Have Much to Offer Pharma

Martin Düblin, One One Eleven

Rock Out at the 4th PDA Europe Annual Meeting

Rebecca Stauffer, PDA

The Future of Pharma is Coming to Europe

Borke Van Belle, Janssen J&J, and Toni Manzano, Bigfinite

Building an Efficient QRM Strategy

Lara Iovino, Thermo Fisher Scientific, and Nominations Chair, PDA Metro Chapter

A Patient’s Life Depends on Product Quality

Jason O’Hare, Charles River

Air Bubbles versus Transparent Particles

John MacEwen, Körber Medipak Systems NA Inc

The Pharmacopeia in the 21st Century

Susanne Keitel, PhD, EDQM

Future Lies in Continuous Manufacturing Technology

Bei Ma, Pinea Group

B. cepacia: What is it and Why is it a Concern?

Marc Baiget Francesch, Tiselab

Deep Dive into Biosimilars Continues

Stephan Krause, AstraZeneca, Emanuela Lacana, U.S. FDA, and Rebecca Stauffer, PDA

PDA Comments: Viral Testing for Gene Therapies

Rebecca Stauffer, PDA

Rapid Micro Methods Carry Potential

Tony Cundell, PhD, Microbiological Consulting, and Michael Miller, PhD, Microbiology Consultants

PDA Addresses LER in TR, Forthcoming Book

Rebecca Stauffer, PDA

NE Chapter Elects New Board, Plus Cold Storage

Henry Brush, Zagfen, New England Chapter Member-at-Large

Our Data Integrity Journey Has Only Just Begun

Jackie Veivia-Panter, Legend Biotech

The Challenges of Visually Inspecting IV Bags

Florian Krickl, Vitronic